Ferric derisomaltose

Medication

  • US DailyMed: Ferric_derisomaltose
Routes of
administrationIntravenous (IV)ATC code
  • None
Legal statusLegal status
Identifiers
  • iron(3+);(2S,3R,4R,5R)-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyhexane-1,2,3,4,5-pentol
CAS Number
  • 1345510-43-1
PubChem CID
  • 86278348
DrugBank
  • DB15617
UNII
  • AHU547PI9H
KEGG
  • D11808
Chemical and physical dataFormulaC18H34FeO16+3Molar mass562.299 g·mol−13D model (JSmol)
  • Interactive image
  • C(C1C(C(C(C(O1)OCC2C(C(C(C(O2)OCC(C(C(C(CO)O)O)O)O)O)O)O)O)O)O)O.[Fe+3]
InChI
  • InChI=1S/C18H34O16.Fe/c19-1-5(21)9(23)10(24)6(22)3-31-17-16(30)14(28)12(26)8(34-17)4-32-18-15(29)13(27)11(25)7(2-20)33-18;/h5-30H,1-4H2;/q;+3/t5-,6+,7+,8+,9+,10+,11+,12+,13-,14-,15+,16+,17-,18-;/m0./s1
  • Key:JTQTXQSGPZRXJF-DOJSGGEQSA-N

Ferric derisomaltose (FDI), sold under the brand name Monoferric among others, is a medication for the treatment of iron deficiency anemia (IDA) in adults who have intolerance to oral iron or have had unsatisfactory response to oral iron or who have non-hemodialysis dependent chronic kidney disease (NDD-CKD).[4] It was approved for use in the United States in January 2020.[4][5][6] It is given intravenously.[4]

References

  1. ^ "Monofer iron (as ferric derisomaltose) 1000 mg/10 mL solution for injection vial (290834)". Therapeutic Goods Administration (TGA). 26 May 2022. Retrieved 9 April 2023.
  2. ^ "Prescription medicines and biologicals: TGA annual summary 2017". Therapeutic Goods Administration (TGA). 21 June 2022. Retrieved 31 March 2024.
  3. ^ "Search Page - Drug and Health Product Register". 23 October 2014.
  4. ^ a b c d "Monoferric- ferric derisomaltose solution". DailyMed. 24 January 2020. Retrieved 16 February 2020.
  5. ^ "Monoferric approval letter" (PDF). U.S. Food and Drug Administration (FDA). 16 January 2020. Retrieved 16 February 2020. Public Domain This article incorporates text from this source, which is in the public domain.
  6. ^ "Drug Approval Package: Monoferric Injection". U.S. Food and Drug Administration (FDA). 7 May 2020. Retrieved 13 August 2020.
  • v
  • t
  • e
ErythropoietinsIron supplements
Vitamin B12 and
folic acid supplementsHIF prolyl-hydroxylase inhibitorsOther
Portal:
  • icon Medicine


Stub icon

This drug article relating to the blood and blood forming organs is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e